Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.49 |
| ▸ | NPY4R | P50391 | 12/20 | 0.42 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.41 |
| ▸ | NPY1R | P25929 | 8/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.40 |
| ▸ | NPY2R | P49146 | 5/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.40 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.40 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.40 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.40 |
| ▸ | TFPI | P10646 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16509130 | 0.87 | NPY4R (0.44) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL16508601 | 0.85 | NPY4R (0.47) | TASP1NPY4RKISS1RNPY1RNPY5R | |
| SCHEMBL16509027 | 0.84 | NPY4R (0.52) | NPY4RKISS1RNPY1RNPY5RNPY2R | |
| SCHEMBL30777485 | 0.81 | NPY4R (0.46) | TASP1NPY4RNPY1RNPY5RNPY2R | |
| Leupeptin SCHEMBL583830 | 0.79 | NPY4R (0.46) | NPY4RKISS1RNPY1RNPY5RNPY2R | |
| Leupeptin SCHEMBL11021602 | 0.79 | NPY4R (0.46) | NPY4RKISS1RNPY1RNPY5RNPY2R | |
| Leupeptin SCHEMBL4669504 | 0.79 | NPY4R (0.46) | NPY4RKISS1RNPY1RNPY5RNPY2R | |
| Leupeptin SCHEMBL13933715 | 0.79 | NPY4R (0.46) | NPY4RKISS1RNPY1RNPY5RNPY2R | |
| SCHEMBL11094153 | 0.78 | SMN1; SMN2 (0.42) | NPY4RNPY1RNPY5RNPY2R | |
| Leupeptin SCHEMBL11596919 | 0.78 | NPY4R (0.46) | NPY4RKISS1RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110301087-A1 | CRF1 RECEPTOR COMPOUNDS | ANCHOR THERAPEUTICS, INC. | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301087-A1 | CRF1 RECEPTOR COMPOUNDS | CRHR1, CRH, CRHR2 | TASP1 2780/4885NPY4R 109/4885KISS1R 363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.